Company / Current Assets
STANDARD BIOTOOLS INC. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$454.3M
FY2025
5-year range
$72.1M / $454.3M
FY2021-FY2025
Trend
+20.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $72M in FY2021 to $454M in FY2025.
Based on SEC 10-K filings.
$454M in FY2025 with a 5-year CAGR of +31.0%.
Improved from $158M to $454M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +29.6%
- 5-Year CAGR
- +31.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +31.0%, indicating consistent growth.
- In FY2025, current assets increased 20.9% year-over-year.
- Lowest current assets in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $454.3M | +20.9% |
| FY2024 | $375.9M | +137.6% |
| FY2023 | $158.2M | -24.2% |
| FY2022 | $208.8M | +189.8% |
| FY2021 | $72.1M | -38.8% |
| FY2020 | $117.7M | +22.4% |
| FY2019 | $96.1M | +1.2% |
| FY2018 | $95.0M | +0.2% |
| FY2017 | $94.8M | -1.9% |
| FY2016 | $96.7M | -32.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026